Stock APRE APREA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Aprea Therapeutics, Inc.

Equities

APRE

US03836J2015

Delayed Nasdaq
Other stock markets
 10:32:53 2024-04-19 am EDT 		5-day change 1st Jan Change
5.6 USD -0.18% Intraday chart for Aprea Therapeutics, Inc. -1.93% +19.15%
Apr. 10 Aprea Therapeutics, Inc. Announces Presentations on Its Next Generation Wee1 Inhibitor, Apr-1051, and A Novel Macrocyclic ATR Inhibitor, ATRN-119, At AACR Annual Meeting 2024 CI
Mar. 27 Wedbush Raises Aprea Therapeutics' PT to $11 From $9 After Layering In Recent Financing, Maintains Outperform Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. APRE Stock
  4. Revisions Aprea Therapeutics, Inc.